In focus · trending topic

Acute Myeloid Leukemia

114 stories · following the connections

Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M for Relapsed or Refractory AML Patients

By Nasdaq OMXFeb 6, 2018, 12:30 PM UTC

Actinium Pharmaceuticals to Present at the BIO CEO & Investor Conference

By Nasdaq OMXFeb 5, 2018, 9:15 PM UTC

Actinium Pharmaceuticals Announces Rights Offering

By Nasdaq OMXFeb 1, 2018, 9:06 PM UTC

Actinium Pharmaceuticals Provides Update on Pivotal Phase 3 Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial Continue

By Nasdaq OMXDec 27, 2017, 2:00 PM UTC

Actinium Pharmaceuticals Announces Positive Preliminary Results from Phase 2 Trial for Actimab-A Highlighted at 59th American Society of Hematology Annual Meeting

By Nasdaq OMXDec 11, 2017, 11:30 AM UTC

Rafael Pharmaceuticals to Present New Data Validating Efficacy of CPI-613 in Treating Acute Myeloid Leukemia at the 2017 American Society of Hematology Annual Meeting & Exposition

By Nasdaq OMXDec 7, 2017, 1:55 PM UTC

Actinium Pharmaceuticals Unveils Actimab-MDS and Planned Phase 2 Trial in Myelodysplastic Syndromes Targeted at Patients with High-Risk p53+ Genetic Mutations

By Nasdaq OMXDec 5, 2017, 12:30 PM UTC

Actinium Pharmaceuticals Highlights Strong Presence at 59th Annual American Society of Hematology Meeting Evidenced by Clinical Development Progress and Results Showcasing its AWE Technology Platform

By Nasdaq OMXNov 29, 2017, 12:32 PM UTC